Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and ...
Plus Therapeutics Inc.: Plus Therapeutics Introduces REYOBIQ, FDA-Accepted Proprietary Name for Lead Drug Candidate
REYOBIQ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and Recurrent Glioblastoma (GBM) HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus ...
Finanznachrichten5d
Telix Pharmaceuticals Limited: Illuccix Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...
The Business Standard20h
Shaping up realistic policies for upcoming budget
The national budget for FY2025-26 presents an opportunity to frame policies that align with the country’s needs and streamline the tax-to-GDP ratio ...
Illuccix® Approved For Prostate Cancer Imaging In Brazil: First Marketing Authorization In Latin America
MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX , Telix, the C ...
Is Eli Lilly and Company (LLY) the Best Diabetes Stock to Buy According to Billionaires?
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409
The IDEA team will help guide Candel’s commercial strategy development and support the Company’s commercial projects related to CAN-2409. Through this partnership, Candel will gain access to a ...
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
No. 5 / 2025Zealand Pharma increases its share capital as a result of the exercise of employee warrantsCopenhagen, ...
Johnson & Johnson is the latest pharma giant to court Trump with new investment plans
Johnson & Johnson (JNJ) is joining Eli Lilly (LLY) in attempting to court favor with President Donald Trump by announcing ...
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Regeneron Pharmaceuticals Inc. closed 44.49% short of its 52-week high of $1,211.20, which the company reached on August 27th ...
Taiwan News6d
Advanced Therapeutics Pharmaceutical Outsourcing Market to Reach USD 11.19 Billion by 2032, Expanding at a 4.4% CAGR
Report Ocean has released a market research report on the Advanced Therapeutics Pharmaceutical Outsourcing industry, covering 150+ countries and analyzing over 1,00000 published and forthcoming ...